Baiji Shenzhou (688235.SH) released its financial results for 2024, with operating revenue of 27.214 billion yuan, a year-on-year increase of 56.19%.

Wisdom Financial News APP, BeiGene (688235.SH) released its annual report for the year 2024, with the company's operating income reaching 27.214 billion RMB, a year-on-year increase of 56.19%. During the reporting period, the company focused on the research and development, production, and commercialization of innovative drugs, with normal progress in production and operation activities and a healthy cash flow situation. The company has established certain competitive advantages in research, clinical development, commercialization, and production, with the aim of driving the company's business towards the future.